UNCY · Unicycive Therapeutics, Inc.

$5.57 +0.06 (+1.00%) At close · Aug 17

Market Cap

$153.48M

27.86M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shalabh Gupta	M.D., Chief Executive Officer	$572,000	$543,400	—	$1,324,484	—	—	$2,439,884
Pramod Gupta	Ph.D., Executive VP Pharmaceutical and Business Operations	$468,000	$222,300	—	$464,971	—	—	$1,155,271
Doug Jermasek	Executive VP, Corporate Strategy	$363,000	$45,375	—	$464,971	—	—	$873,346

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shalabh Gupta	M.D., Chief Executive Officer	$550,000	$550,000	—	$2,971,562	—	—	$4,044,062
Pramod Gupta	Ph.D., Executive VP Pharmaceutical and Business Operations	$450,000	$225,000	—	$859,479	—	—	$1,523,229
Doug Jermasek	Executive VP, Corporate Strategy	$330,000	$82,500	—	$859,479	—	—	$1,267,854

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shalabh Gupta	M.D., Chief Executive Officer	$550,000	$908,012	—	$53,723	—	—	$1,511,735
Pramod Gupta	Ph.D., Executive VP Pharmaceutical and Business Operations	$450,000	$329,178	—	$17,491	—	—	$796,669
Doug Jermasek	Executive VP, Corporate Strategy	$330,000	$100,808	—	$34,357	—	—	$465,165

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shalabh Gupta	M.D., Chief Executive Officer	$669,775	$124,187	—	$330,729	—	—	$1,124,691
Pramod Gupta	Ph.D., Executive VP Pharmaceutical and Business Operations	$187,500	—	—	$231,555	—	$68,750	$487,805
John Townsend	CPA, Chief Financial Officer	$91,667	—	—	$185,253	—	$106,197	$383,117

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shalabh Gupta	M.D., Chief Executive Officer	$495,000	$148,500	—	—	—	—	$643,500
Pramod Gupta	Ph.D., Executive VP Pharmaceutical and Business Operations	—	—	—	$212,250	—	$60,000	$272,250
John Townsend	CPA, Chief Financial Officer	—	—	—	—	—	$39,750	$39,750

Executive changes

Person	Role	Change	Effective	Filed
Gaurav Aggarwal	director	Resigned	2026-04-06	2026-04-06
Gaurav Aggarwal	Board of Directors	Appointed	—	2023-03-06
Gaurav Aggarwal, MD	Board of Directors	Appointed	—	2023-03-06

Key facts CIK 1766140 CUSIP 90466Y202 13F (30d) 81 filings 79 filers Visit website Investor relations